Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study

Sandro Barni, Luca Livraghi, Adriano Gravina, Francesca Martella, Loretta D'Onofrio, Maria Morritti, Andrea Michelotti, Patrizia Vici, Lucia Mentuccia, Luca Porcu, Michele Orditura, Fabio Puglisi, ESEMPiO Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)990-993
Number of pages4
JournalJournal of Geriatric Oncology
Issue number6
Publication statusPublished - Nov 2019


  • Aged
  • Eribulin
  • Metastatic breast cancer
  • Safety

Cite this